Literature DB >> 10374705

Oral vaccination of white-tailed deer using a recombinant Bacillus Calmette-Guérin vaccine expressing the Borrelia burgdorferi outer surface protein A: prospects for immunocontraception.

L A Miller1, B E Johns, D J Elias, G J Killian.   

Abstract

PROBLEM: Reduction of excess numbers of white-tailed deer (Odocoileus virginianus) is a prime example of a potential use for immunocontraception as a means of wildlife population management. Oral vaccination appears to be the most pragmatic way to deliver immunocontraceptive vaccines to free-roaming populations of deer, but there was little, if any, prior evidence that oral vaccination is a viable concept in deer. METHOD OF STUDY: We used live Bacillus Calmette-Guérin (BCG) in a recombinant form (rBCG), which expressed Borrelia burgdorferi outer surface protein A, to test whether deer vaccinated orally with a specific antigen expressed in a live vector produce detectable antibody titers.
RESULTS: The data indicate that oral vaccination of deer with an expressed antigen is feasible, as demonstrated by peak antibody titers to the expressed antigen. Also, peak titers measured by enzyme-linked immunosorbent assay were highest in orally vaccinated deer: 1600 in deer vaccinated by injection and 6400 in those vaccinated orally.
CONCLUSIONS: The results of this study demonstrate that it is feasible to vaccinate deer orally with a live vector.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10374705     DOI: 10.1111/j.1600-0897.1999.tb00439.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  2 in total

Review 1.  BOARD INVITED REVIEW: Immunocontraception as a possible tool to reduce feral pig populations: recent and future perspectives.

Authors:  Claudio Oliviero; Lena Lindh; Olli Peltoniemi
Journal:  J Anim Sci       Date:  2019-05-30       Impact factor: 3.159

2.  Assessing risks to non-target species during poison baiting programs for feral cats.

Authors:  Tony Buckmaster; Christopher R Dickman; Michael J Johnston
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.